KRAS and cancer: Thus, in cancers that occur early in individuals’ lives (age < 50 years), mutations in SMAD4 and PIK3CA tend to co-occur, whereas mutations in TP53 and GNAS and mutations in SOX9 and KRAS or TP53 tend to be mutually exclusive.